National Workshop on Reprioritization of Diseases under Integrated Disease Surveillance Programme
WHO Country Office for India in collaboration with the National Centre for Disease Control (NCDC), Ministry of Health & Family Welfare (MoHFW), Government of India organized a two-day National Workshop on Reprioritization of Diseases under the Integrated Disease Surveillance Programme (IDSP), at New Delhi on 6 -7 December 2016.
The main objective of the workshop was to reprioritize the diseases/disease groups under IDSP, standardize case data elements, data collection methods and review IT tools.
The workshop highlighted the need for collecting more data on mortality and conducting select disease burden studies. It was also suggested that the reprioritization exercise must consider disease conditions that have a national core list and with state specific additions.
Most experts at the consultation were of the opinion that IDSP should consider limited diseases for routine reporting that lead to public health action. As regards inclusion of noncommunicable diseases and other events, it was felt that it was a bit premature to expand the scope to these health events. These could be taken up in a phased manner.
The workshop showcased IDSP IT tools piloted in the country, which capture real time data. It was agreed that there was an urgent need to build on these pilots. The ICT recommendations included developing a comprehensive Information Management Master Plan Document, designing a dashboard frame, developing agreements to obtain data from other programmes/activities and an Operations Plan Document to include data and information needs related to all activities and functions of IDSP, both at the centre and the states.
There was unanimity that strengthening the surveillance processes must include bringing into the ambit the private sector with high quality laboratory support and capacity-building at different levels. IDSP must also consider integration of other vertical programmes for capturing data into a common dashboard.
The meeting concluded with a revised list on 32 disease conditions in the rank of priority and a final report will be made available soon.
Over 80 subject matter experts, representing states, central, academia, WHO and US CDC participated in the workshop.